Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 4

Treatment of pseudomyxoma peritonei cases

Psödomikzoma peritonei vakalarında tedavi

Pages
346–349
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Though the number of chemotherapy applied cases was low, it was observed that chemotherapy was not effectine enough and that radical surgery was more benefical.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Pseudomyxoma peritonei is very rare, and its exact pathogenesis is unknown.
📊
Key Findings & Data:The aim of this study our 15-year experience with pseudomyxoma peritonei cases and therapy during this period Material and Method: In this study; we presented 8 pseudomyxoma peritonei cases who were diagnosed and treated at last 15 years in our General Surgery Clinic, Meram Medical faculty, Selçuk University.
💡
Conclusion & Impact:Though the number of chemotherapy applied cases was low, it was observed that chemotherapy was not effectine enough and that radical surgery was more benefical.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Pseudomyxoma peritonei is very rare, and its exact pathogenesis is unknown. It is characterized by intra-abdominal gelatinous fluid collections. The aim of this study our 15-year experience with pseudomyxoma peritonei cases and therapy during this period Material and Method: In this study; we presented 8 pseudomyxoma peritonei cases who were diagnosed and treated at last 15 years in our General Surgery Clinic, Meram Medical faculty, Selçuk University. Conclusion: All cases were applied aggressive surgery resection. However, for 4 cases recurrent repair was applied(Total 11 laparatomia). Though the number of chemotherapy applied cases was low, it was observed that chemotherapy was not effectine enough and that radical surgery was more benefical.

Özet

Amaç: Pseudomyxoma peritonei çok nadiren görülen ve esas kaynağı tam olarak bilinmeyen. Karın içinde jelatinöz karakterde sıvı birikimi ile karekterili bir hastalıktır. Bu çalışmanın amacı 15 yıllık psödomikzoma peritonei vakalarını ve bu peryoddaki tedavilerini sunmak. Gereç ve Yöntem: Çalışmada Selçuk Üniversitesi Meram Tıp Fakültesi Genel Cerrahi Kliniği’nde son 15 yılda teşhis ve tedavi edilen 8 pseudomyxoma peritonei vakası alındı.Sonuç: Vakaların tamamında agresif cerrahi rezeksiyon uygulandı, buna rağmen 4 vakada nüks nedeniyle mükerrer rezeksiyon (Toplam 11 laparotomi) uygulandı. Kemoterapi verilen az sayıda vakada kemoterapinin yeterince etkili olmadığı, radikal cerrahinin daha önemli olduğu gözlendi.

🔖

Cite This Article

BELVİRANLI, M., VATANSEV, C., AKSOY, F., YILMAZ, O., TEKİN, A. (2022). Treatment of pseudomyxoma peritonei cases. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 4, 346–349. https://ajindex.com/articles/502708

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Werth R. Klinische and Anatomische Untersuchungen Zur Lehre von den Bauchgeschwullsten and der Laparotomie. Arch Gynecol Obstet 1884;24:100–18
  2. Ohta Y, Shima Y, Sasaki N, Nishida T, Yamayoshi T, Adachi A. Succesful treatment of pseudomyxoma peritonei using combination chemotherapy of intraperitoneal low-dose CDDP and oral 5’-DFUR adminstration. Gan To Kagaku Ryoho. 1998; 25: 929-32 3. Van Ruth S, Acherman YI, van de Vijwer MJ, Hart AA, Verwaal VJ, Zoetmulder FA. Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol. 2003;29:682–88
  3. Sherer D.M., Abulafia O.and Eliakim R., Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 2001; 51:73–80
  4. Hosch WP, Rudi J, Stremmel W. Therapy of pseudomyxoma peritonei of appendiceal origin-surgical resection and intraperitoneal chemotherapy. Z Gastroenterol. 1999; 37: 615-622 6.Mukherjee, A. Parvaiz, T.D. Cecil and B.J. Moran, Pseudomyxoma peritonei usually originates from the appendix a review of evidence, Eur J Gynaecol Oncol 2004; 25: 411–414
  5. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144-1153
  6. Sugarbaker PH. Pseudomyxoma peritonei. Cancer Treat Res. 1996; 81: 105-119 9. Dejong CH, Booster MH, Theunissen PH, Beets GL, van Duin CJ. Pseudomyxoma peritonei. Ned Tijdschr Geeneskd. 1997; 141: 1196-1198 10. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg. 1998; 85: 1332-1339 11. Shin HJ, Sneige N. Epithelial cells and other cytologic features of pseudomyxoma peritonei in patients with ovarian and/or appendiceal mucinous neoplasms: a study of patients including 5 men. Cancer 2000; 90: 17-23 12. Keating JP, Frizelle FA. Use of ultrasonic surgical aspirator in operative cytoreduction of pseudomyxoma peritonei. Dis Colon Rectum. 2000; 43: 559-560 13. An experimental study of mucocele of the appendix and pseudomyxoma peritonei. J Pathol Bacteriol. 1949;61:217-225 14. Pestien SR, Esquivel J, Sugarbaker PH. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol. 2000; 7: 199-203 15. Laitinen JO, Tenhunen M, Kairemo KJ. Absorbed dose estimates for 131I-Labelled monoclonal antibody therapy in patients with intraperitoneal pseudomyxoma. Nucl Med Commun. 2000; 21: 355-360 16. Pestieau SR, Wolk R, Sugarbaker PH. Congenital pleuroperitoneal in a patient with pseudomyxoma